Morgan Leigh 4
4 · Kymera Therapeutics, Inc. · Filed Jul 8, 2022
Insider Transaction Report
Form 4
Morgan Leigh
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-06+24,000→ 24,000 totalExercise: $23.59Exp: 2032-07-05→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on July 6, 2022..